Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population

Renée Bazin, Samuel Rochette, Josée Perreault, Marie-Josée Fournier, Yves Grégoire, Amélie Boivin, Antoine Lewin, Marc Germain, Christian Renaud
doi: https://doi.org/10.1101/2022.08.15.22278798
Back to top
Posted August 18, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Development and use of a method based on the anti-N reactivity of longitudinal samples to better estimate SARS-CoV-2 seroprevalence in a vaccinated population
Renée Bazin, Samuel Rochette, Josée Perreault, Marie-Josée Fournier, Yves Grégoire, Amélie Boivin, Antoine Lewin, Marc Germain, Christian Renaud
medRxiv 2022.08.15.22278798; doi: https://doi.org/10.1101/2022.08.15.22278798
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area